loading page

Odd chain fatty acids and odd chain phenolic lipids (alkylresorcinols): Essential for diet?
  • +1
  • Kelly Dornan,
  • Aynur Gunenc,
  • B. Dave Oomah,
  • Farah Hosseinian
Kelly Dornan
Author Profile
Aynur Gunenc
Author Profile
B. Dave Oomah
(Retired), Formerly with the National Bioproducts and Bioprocesses Program, Pacific Agri-Food Research Centre,
Author Profile
Farah Hosseinian
Carleton University
Author Profile

Abstract

Odd chain fatty acids (C15:0 and C17:0) from dairy fat as well as odd chain phenolic lipids (alkylresorcinols) from whole grain are commonly reviewed as candidate biomarkers for dietary analysis and their ingestion are inversely related to chronic disease risks. Therefore, low levels of dietary intake of these odd chain molecules may be related to higher risk of physiological states that cause chronic diseases or mortality. It is a prerequisite to examine and understand their main role in beneficial health effects in disease prevention. We propose odd chain fatty acids (OC-FA) and most importantly odd chain phenolic lipids (OC-PL) as potential essential dietary compounds since they play key roles in physiological mechanisms. This review evaluates potential roles of OC-FA and OC-PL in mitigating chronic diseases in vitro and in vivo studies to support our hypothesis for odd chain molecules as essential dietary lipids. Further studies are needed to investigate the relationship between reduced intake of OC-FA and OC-PL containing foods and susceptibilities to chronic diseases.

Peer review status:ACCEPTED

09 Jan 2021Submitted to Journal of the American Oil Chemists' Society
11 Jan 2021Submission Checks Completed
11 Jan 2021Assigned to Editor
28 Jan 2021Reviewer(s) Assigned
06 Mar 2021Review(s) Completed, Editorial Evaluation Pending
09 Mar 2021Editorial Decision: Revise Major
31 Mar 20211st Revision Received
31 Mar 2021Submission Checks Completed
31 Mar 2021Assigned to Editor
01 Apr 2021Reviewer(s) Assigned
05 May 2021Review(s) Completed, Editorial Evaluation Pending
08 May 2021Editorial Decision: Accept